These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1352109)

  • 1. An international appraisal of the minimum duration of chronic animal toxicity studies.
    Lumley CE; Parkinson C; Walker SR
    Hum Exp Toxicol; 1992 May; 11(3):155-62. PubMed ID: 1352109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The questionable value of long-term animal toxicity studies: a regulatory dilemma.
    Lumley CE; Walker SR
    Arch Toxicol Suppl; 1986; 9():237-9. PubMed ID: 3468901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical appraisal of the duration of chronic animal toxicity studies.
    Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1986 Mar; 6(1):66-72. PubMed ID: 3704209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The duration of non-rodent toxicity studies for pharmaceuticals. International Conference on Harmonication (ICH).
    DeGeorge JJ; Meyers LL; Takahashi M; Contrera JF
    Toxicol Sci; 1999 Jun; 49(2):143-55. PubMed ID: 10416259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.
    Sewell F; Chapman K; Baldrick P; Brewster D; Broadmeadow A; Brown P; Burns-Naas LA; Clarke J; Constan A; Couch J; Czupalla O; Danks A; DeGeorge J; de Haan L; Hettinger K; Hill M; Festag M; Jacobs A; Jacobson-Kram D; Kopytek S; Lorenz H; Moesgaard SG; Moore E; Pasanen M; Perry R; Ragan I; Robinson S; Schmitt PM; Short B; Lima BS; Smith D; Sparrow S; van Bekkum Y; Jones D
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):413-29. PubMed ID: 25078890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for a control animal pathology database: an international survey.
    McAuslane JA; Lumley CE; Walker SR
    Hum Exp Toxicol; 1991 May; 10(3):205-13. PubMed ID: 1678951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
    Spurling NW; Carey PF
    Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
    Clarke J; Hurst C; Martin P; Vahle J; Ponce R; Mounho B; Heidel S; Andrews L; Reynolds T; Cavagnaro J
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):2-22. PubMed ID: 17998153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmonization of guidelines for toxicity testing of pharmaceuticals by 1992.
    Speid LH; Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):179-211. PubMed ID: 2259757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chronic toxicology studies in revealing new toxicities.
    Galijatovic-Idrizbegovic A; Miller JE; Cornell WD; Butler JA; Wollenberg GK; Sistare FD; DeGeorge JJ
    Regul Toxicol Pharmacol; 2016 Dec; 82():94-98. PubMed ID: 27769827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.
    Chapman K; Sewell F; Allais L; Delongeas JL; Donald E; Festag M; Kervyn S; Ockert D; Nogues V; Palmer H; Popovic M; Roosen W; Schoenmakers A; Somers K; Stark C; Stei P; Robinson S
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):27-38. PubMed ID: 23602904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
    Dahlem AM; Allerheiligen SR; Vodicnik MJ
    Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing.
    Weingand K; Brown G; Hall R; Davies D; Gossett K; Neptun D; Waner T; Matsuzawa T; Salemink P; Froelke W; Provost JP; Dal Negro G; Batchelor J; Nomura M; Groetsch H; Boink A; Kimball J; Woodman D; York M; Fabianson-Johnson E; Lupart M; Melloni E
    Fundam Appl Toxicol; 1996 Feb; 29(2):198-201. PubMed ID: 8742316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Points to Consider in Designing and Conducting Juvenile Toxicology Studies.
    Kim NN; Parker RM; Weinbauer GF; Remick AK; Steinbach T
    Int J Toxicol; 2017; 36(4):325-339. PubMed ID: 28466670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species selection considerations for preclinical toxicology studies for biotherapeutics.
    Bussiere JL
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):871-7. PubMed ID: 18624676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.